Insights

Clinical GMP Focus Fraunhofer IZI emphasizes GMP-compliant manufacture of investigational medicinal products and clinical-oriented support for manufacturing authorizations. This presents a sales opportunity to offer advanced manufacturing scalability services, regulatory consulting, and quality assurance partnerships to accelerate clinical programs in regenerative medicine, oncology, ischemia and autoimmune/infectious disease areas.

Regenerative Medicine Depth Core competencies lie in regenerative medicine with emphasis on cell therapy, diagnostics and biobanking. Potential upsell includes contract research, method/material/product optimization, and collaborative development of cell therapies or diagnostic assays leveraging their screening and validation capabilities.

Contract Research Engine The institute frequently engages in contract research for biotech and medical tech companies, hospitals, and diagnostic labs. This aligns with offering end-to-end CRO services, pilot studies, analytical method development, and quality-controlled manufacturing as a service to shorten time-to-market for clients.

Tech Stack Modern Utilizes SAP HANA, SAP HCM, Ansible, NoSQL, JSON-LD and embedded Linux among others, indicating readiness for data-intensive, regulatory-compliant workflows and digital transformation. Opportunities exist to propose data management, ERP integration, and automation solutions to streamline research operations and GMP documentation.

External Collaboration Network Active engagement with partners across solar, polymer research, imaging, and materials fields suggests openness to cross-industry collaboration and funded joint programs. Sales angle includes proposing multi-disciplinary partnerships, grant-based projects, and shared facilities access to broaden application areas and funding avenues.

Fraunhofer IZI Tech Stack

Fraunhofer IZI uses 8 technology products and services including Ansible, NoSQL, SAP HANA, and more. Explore Fraunhofer IZI's tech stack below.

  • Ansible
    Configuration Management
  • NoSQL
    Database
  • SAP HANA
    Database Management
  • Microsoft Copilot Studio
    Generative Ai
  • SAP Human Capital Management
    Human Resource Management System
  • JSON-LD
    Javascript Frameworks
  • Embedded Linux
    Operating Systems & Computing Languages
  • macOS
    Operating Systems & Computing Languages

Media & News

Fraunhofer IZI's Email Address Formats

Fraunhofer IZI uses at least 2 format(s):
Fraunhofer IZI Email FormatsExamplePercentage
First.Last@izi.fraunhofer.deJohn.Doe@izi.fraunhofer.de
97%
Last.First@izi.fraunhofer.deDoe.John@izi.fraunhofer.de
3%
First.Last@fraunhofer.deJohn.Doe@fraunhofer.de
92%
First@fraunhofer.deJohn@fraunhofer.de
7%
FLast@fraunhofer.deJDoe@fraunhofer.de
1%

Frequently Asked Questions

What is Fraunhofer IZI's official website and social media links?

Minus sign iconPlus sign icon
Fraunhofer IZI's official website is fraunhofer.de and has social profiles on LinkedIn.

How much revenue does Fraunhofer IZI generate?

Minus sign iconPlus sign icon
As of July 2026, Fraunhofer IZI's annual revenue is estimated to be $10M - $25M.

What is Fraunhofer IZI's SIC code NAICS code?

Minus sign iconPlus sign icon
Fraunhofer IZI's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fraunhofer IZI have currently?

Minus sign iconPlus sign icon
As of July 2026, Fraunhofer IZI has approximately 267 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Head Of Department "gmp Cell And Gene Therapy": G. S.Head Of Diagnostics Department: D. K.Head Of Laboratory: R. W.. Explore Fraunhofer IZI's employee directory with LeadIQ.

What industry does Fraunhofer IZI belong to?

Minus sign iconPlus sign icon
Fraunhofer IZI operates in the Biotechnology Research industry.

What technology does Fraunhofer IZI use?

Minus sign iconPlus sign icon
Fraunhofer IZI's tech stack includes AnsibleNoSQLSAP HANAMicrosoft Copilot StudioSAP Human Capital ManagementJSON-LDEmbedded LinuxmacOS.

What is Fraunhofer IZI's email format?

Minus sign iconPlus sign icon
Fraunhofer IZI's email format typically follows the pattern of First.Last@izi.fraunhofer.de. Find more Fraunhofer IZI email formats with LeadIQ.

When was Fraunhofer IZI founded?

Minus sign iconPlus sign icon
Fraunhofer IZI was founded in 2005.
Fraunhofer IZI logo

Fraunhofer IZI

Biotechnology ResearchSaxony, Germany201-500 Employees

The Fraunhofer Institute for Cell Therapy and Immunology IZI conducts applied research at the interfaces of medicine, life sciences, and engineering. It provides contract research services to biotechnological, pharmaceutical and medical-technology companies, hospitals, diagnostic laboratories and research facilities, developing, optimizing and validating methods, materials and products within its business units, including Agents, Cell Therapy, and Diagnostic and Biobanking. Its core strengths lie in regenerative medicine, with focus areas in oncology, ischemia, and autoimmune, inflammatory and infectious diseases. The institute takes a clinically oriented approach, performing quality checks and GMP-compliant manufacture of investigational medicinal products, and offering support to obtain manufacturing authorizations and approvals. Based in Leipzig, Saxony, Germany, it is a mid-sized organization employing several hundred people.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
201-500

Section iconFunding & Financials

  • $10M - $25M

    Fraunhofer IZI's revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $10M - $25M

    Fraunhofer IZI's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.